Here Dr. Carmen Guguta, global head of business development and marketing at crystallisation technology provider Technobis Crystallization Systems, explains how new technology is streamlining crystallisation research.
Particle Works launches its second platform, the Automated Library Synthesis (ALiS) System, enabling automation and high-throughput screening of lipid nanoparticle (LNP) formulations and mRNA candidates in early-stage drug development.
Birmingham Biotech, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, launches NoriZite Nasal Spray, an easy-to-use nasal device designed to block and trap inhaled virus particles, into the UK market.
Ahead of World Stroke Day, David Budd, CEO of genedrive plc, underscores the growing role of pharmacogenetics in personalised medicine and how its application can decrease the odds of secondary cerebrovascular disease.
Marco Pelka, market manager PCE of Mettler-Toledo, explains how manufacturers and packaging companies in this field can harness product inspection to ensure they produce high quality liquid pharmaceutical products.
Luigi Boltri, PH.D., senior director, Pharmaceutical Sciences, Adare Pharma Solutions, addresses the challenges of paediatric formulations, and how specialised technology platforms can provide ease of application and improve patient outcomes.
Christina Smolke, PhD, co-founder and CEO of Antheia, describes how biomanufacturing can provide sustainable, high-quality APIs and KSMs, and de-risk pharmaceutical production by localising and streamlining supply chains.
Yuliyana Manolova, director Business Development Contract Manufacturing at Acino, explores the challenges generics manufacturing in Europe faces, and the actions pharma companies must take to better navigate the current market environment.
LLS Health's experts, Joey Glassco, MBA, Injectable Drug Delivery, and Nick DiFranco, MEM, global market segment manager, share the API solubility puzzle that the pharma industry faces and how to solve it.
Punya Abbhi, COO at Celegence, explains how the adoption of digital technologies enables companies to manage their regulatory compliance requirements in a more efficient and reliable manner.
Allen Jacques, industry thought leader at Kinaxis, shares that by using technology to improve supply chain visibility and transparency, companies can plan for volatility and identify potential disruption before it occurs,
Lisa Caralli, Science and Technology director, Pharmaceutics, Catalent, discusses the methods that formulation scientists can undertake on small quantities of API to achieve the greatest possible results to progress through drug product development.
